Ranbaxy Laboratories has placed a net loss of Rs464.58 cr

Ranbaxy Laboratories has placed a net loss of Rs464.58 cr for the qtr closed Sept 30, 2011 when compared to net gain of Rs307.94 cr for the qtr closed Sept 30, 2010.

The total revenue of the group surged by 8.71percent to Rs2197.56 cr for the qtr closed Sept 30, 2011 from Rs2021.58 cr for the qtr closed Sept 30, 2010.

Be Sociable, Share!
Tags:

Stock Market Basics For Beginners

Common shares

Common shares Common shares are standard shares with no particular restrictions or rights and have the potential to provide the highest financial gain, but ordinary shares (common ...…

Public Provident Fund

Public Provident Fund Public Provident Fund: long-term savings device which has a maturity period of 15 yrs and interest payable at 8 percent per year compounded yearly. A ...…

When Begins Investing

When Begins Investing [ad name="Banner 468 x 60 Text emage"] The quicker one begins investing the better. By investing very early a person allow investment funds a longer period ...…

Secondary Market?

Secondary Market? Secondary Markets refers to a market where securities are traded after being initially offered to the public (IPO) in the primary market, Secondary market comprises ...…

What Is Face Value Of A Share And Debenture?

What Is Face Value Of A Share And Debenture? stated value given to a security by the company. For stocks, it's the original price of the share shown on the certificates for bonds, it's ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics